Terms: = Germ cell tumor AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
237 results:
1. Antiproliferative effect of Potentilla fulgens on glioblastoma cancer cells through downregulation of Akt/mTOR signaling pathway.
Kandemir SI; Ipek P
J Cancer Res Ther; 2023 Oct; 19(7):1818-1824. PubMed ID: 38376284
[TBL] [Abstract] [Full Text] [Related]
2. Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment.
Vagaggini C; Petroni D; D'Agostino I; Poggialini F; Cavallini C; Cianciusi A; Salis A; D'Antona L; Francesconi V; Manetti F; Damonte G; Musumeci F; Menichetti L; Dreassi E; Carbone A; Schenone S
Drug Dev Res; 2024 Feb; 85(1):e22158. PubMed ID: 38349262
[TBL] [Abstract] [Full Text] [Related]
3. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
Bai X; Li S; Luo Y
Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
[TBL] [Abstract] [Full Text] [Related]
4. EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma.
Lv D; Zhong C; Dixit D; Yang K; Wu Q; Godugu B; Prager BC; Zhao G; Wang X; Xie Q; Bao S; He C; Heiland DH; Rosenfeld MG; Rich JN
Mol Cell; 2023 Dec; 83(23):4334-4351.e7. PubMed ID: 37979586
[TBL] [Abstract] [Full Text] [Related]
5. Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis.
Guo D; Jurek R; Beaumont KA; Sharp DS; Tan SY; Mariana A; Failes TW; Grootveld AK; Bhattacharyya ND; Phan TG; Arndt GM; Jain R; Weninger W; Tikoo S
Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2303978120. PubMed ID: 37963252
[TBL] [Abstract] [Full Text] [Related]
6. Network pharmacology-based strategy to investigate the effect and mechanism of α-solanine against glioma.
Wang C; Liu X; Guo S
BMC Complement Med Ther; 2023 Oct; 23(1):371. PubMed ID: 37865727
[TBL] [Abstract] [Full Text] [Related]
7. Indoloquinazoline alkaloids suppress angiogenesis and inhibit metastasis of melanoma cells.
Guo X; Fan A; Qi X; Liu D; Huang J; Lin W
Bioorg Chem; 2023 Dec; 141():106873. PubMed ID: 37734192
[TBL] [Abstract] [Full Text] [Related]
8. Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking.
Su J; Huo M; Xu F; Ding L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1551-1559. PubMed ID: 37668687
[TBL] [Abstract] [Full Text] [Related]
9. Using evolutionary constraint to define novel candidate driver genes in medulloblastoma.
Roy A; Sakthikumar S; Kozyrev SV; Nordin J; Pensch R; Mäkeläinen S; Pettersson M; ; Karlsson EK; Lindblad-Toh K; Forsberg-Nilsson K
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2300984120. PubMed ID: 37549291
[TBL] [Abstract] [Full Text] [Related]
10. EGFR-Induced and c-src-Mediated CD47 Phosphorylation Inhibits TRIM21-Dependent Polyubiquitylation and Degradation of CD47 to Promote tumor Immune Evasion.
Du L; Su Z; Wang S; Meng Y; Xiao F; Xu D; Li X; Qian X; Lee SB; Lee JH; Lu Z; Lyu J
Adv Sci (Weinh); 2023 Sep; 10(27):e2206380. PubMed ID: 37541303
[TBL] [Abstract] [Full Text] [Related]
11. Suppression of sonic hedgehog pathway-based proliferation in glioblastoma cells by small-size silver nanoparticles in vitro.
Skóra B; Masicz M; Nowak P; Lachowska J; Sołtysek P; Biskup J; Matuszewska P; Szychowski KA
Arch Toxicol; 2023 Sep; 97(9):2385-2398. PubMed ID: 37407723
[TBL] [Abstract] [Full Text] [Related]
12. Dynamic interplay between corticosteroid treatment and the role of src-1 gene dysregulation in the progression of WHO-Grade 4 Astrocytoma.
Kurdi M; Fadul MM; Addas BMJ; Faizo E; Alkhayyat S; Bamaga AK; Alsinani T; Katib Y; Okal F; Maghrabi Y; Sabbagh AJ; Moshref R; Albalawi S; Alkhotani A; Halawa TF; Mulla N; Hakamy S; Baeesa S
J Neurooncol; 2023 Jul; 163(3):693-705. PubMed ID: 37402091
[TBL] [Abstract] [Full Text] [Related]
13. Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
Biswas A; Salvucci M; Connor K; Düssmann H; Carberry S; Fichtner M; King E; Murphy B; O'Farrell AC; Cryan J; Beausang A; Heffernan J; Cremona M; Hennessy BT; Clerkin J; Sweeney KJ; MacNally S; Brett F; O'Halloran P; Bacon O; Furney S; Verreault M; Quissac E; Bielle F; Ahmed MH; Idbaih A; Leenstra S; Ntafoulis I; Fabro F; Lamfers M; Golebiewska A; Hertel F; Niclou SP; Yen RTC; Kremer A; Dilcan G; Lodi F; Arijs I; Lambrechts D; Purushothama MK; Kel A; Byrne AT; Prehn JHM
J Neurooncol; 2023 Jun; 163(2):327-338. PubMed ID: 37237151
[TBL] [Abstract] [Full Text] [Related]
14. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
15. Kaempferol suppresses glioma progression and synergistically enhances the antitumor activity of gefitinib by inhibiting the EGFR/src/STAT3 signaling pathway.
Zhou J; Liu Y; Chen J; Xiong N; Yi D
Drug Dev Res; 2023 May; 84(3):592-610. PubMed ID: 36852868
[TBL] [Abstract] [Full Text] [Related]
16. Antitumor mechanism of kangliu pill on gliomas in mice through PI3K-Akt signaling pathway.
Chen F; Cui JJ; Jiang DC; Wang HZ; Zhuang W; Feng YN; Lin XL; Xi SY
J Ethnopharmacol; 2023 May; 307():116252. PubMed ID: 36775078
[TBL] [Abstract] [Full Text] [Related]
17. Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma.
Sadeghi R; Pirankuraim H; Javanshir ST; Arabi M; Bereimipour A; Javanshir HT; Mahmoodzadeh H; Nayernia K
Eye (Lond); 2023 Aug; 37(11):2327-2334. PubMed ID: 36528757
[TBL] [Abstract] [Full Text] [Related]
18. Bioinformatics analysis identified RGS4 as a potential tumor promoter in glioma.
Wu L; Wang J; Zhao J; Yao R; Xu Q; Ma L; Liu J
Pathol Res Pract; 2022 Dec; 240():154225. PubMed ID: 36423402
[TBL] [Abstract] [Full Text] [Related]
19. Bioinformatics Analysis and Experimental Identification of Immune-Related Genes and Immune cells in the Progression of Retinoblastoma.
Chen S; Chen X; Zhang P; Chen S; Wang X; Luo Q; Cui Z; Huang Y; Wan L; Hou X; Yao H; Liu X; He A; Jiang Z; Qiu J; Li Y; Yu K; Zhuang J
Invest Ophthalmol Vis Sci; 2022 Oct; 63(11):28. PubMed ID: 36315123
[TBL] [Abstract] [Full Text] [Related]
20. The AhR-src axis as a therapeutic vulnerability in BRAFi-resistant melanoma.
Paris A; Tardif N; Baietti FM; Berra C; Leclair HM; Leucci E; Galibert MD; Corre S
EMBO Mol Med; 2022 Dec; 14(12):e15677. PubMed ID: 36305167
[TBL] [Abstract] [Full Text] [Related]
[Next]
